Greff; Zoltan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Greff; Zoltan.The latest application filed is for "benzothiophene, benzyloxybenzylidene and indoline derivatives useful for the treatment of tuberculosis".

Company Profile

0.11.17

Greff; Zoltan - Budapest HU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity Grant 10,294,218 - Lori , et al.	2019-05-21
Benzothiophene, Benzyloxybenzylidene And Indoline Derivatives Useful For The Treatment Of Tuberculosis App 20170240522 - RYBNIKER; Jan ; et al.	2017-08-24
Novel 4,6-disubstituted Aminopyrimidine Derivatives Have Anti-hiv Activity App 20170204084 - Lori; Franco ; et al.	2017-07-20
4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity Grant 9,617,225 - Lori , et al. April 11, 2	2017-04-11
4-Pyrimidinylamino-benzenesulfonamide derivatives and their use for the inhibition of polo-like kinase 1 (PLK1) for the treatment of cancer and their use for the treatment of bacterial infections App 20150368209 - GREFF; Zoltan ; et al.	2015-12-24
4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity Grant 9,040,529 - Greff , et al. May 26, 2	2015-05-26
Novel 4,6-disubstituted Aminopyrimidine Derivatives Having Both Aromatic And Halogenic Substituents App 20140057911 - Lori; Franco ; et al.	2014-02-27
4-phenylamino-pyrimidine Derivatives Having Protein Kinase Inhibitor Activity App 20120258968 - Greff; Zoltan ; et al.	2012-10-11
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases Grant 8,084,457 - Choidas , et al. December 27, 2	2011-12-27
Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor App 20090298842 - Pato; Janos ; et al.	2009-12-03
Optical Isomers Of Dihydro-2,3-benzodiazepines And Their Stereoselective Synthesis App 20090233913 - Ling; Istvan ; et al.	2009-09-17
4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and methods for medical intervention against mycobacterial infections App 20090018149 - Missio; Andrea ; et al.	2009-01-15
Heterobicyclic Compounds as Pharmaceutically Active Agents App 20070275962 - Koul; Anil ; et al.	2007-11-29
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases App 20070191344 - Choidas; Axel ; et al.	2007-08-16
2, 3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient Grant 7,189,711 - Ling , et al. March 13, 2	2007-03-13
Polymorphs of a 1-pyrrole derivative, intermediate for the preparation of atorvastatin Grant 7,186,848 - Barkoczy , et al. March 6, 2	2007-03-06
2,3-benzodiazepine derivatives Grant 7,053,082 - Greff , et al. May 30, 2	2006-05-30
Medium and method for enriching, purifying or depleting atp binding proteins from a pool of proteins App 20060105445 - Godl; Klaus ; et al.	2006-05-18
Imidazole compounds and human cellular proteins casein kinase I alpha, delta and epsilon as targets for medical intervention against Hepatitis C Virus infections App 20050203155 - Salassidis, Konstadinos ; et al.	2005-09-15
Polymorphs of a 1-pyrrole derivative, intermediate for the preparation of atorvastatin App 20040249168 - Barkoczy, Jozsef ; et al.	2004-12-09
Process for the preparation of a 3(2H)-pyridazinone-4- substituted amino 5-chloro derivative Grant 6,800,758 - Nagy , et al. October 5, 2	2004-10-05
Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor App 20040171603 - Pato, Janos ; et al.	2004-09-02
Process for the preparation of amorphous atorvastatin calcium App 20040063969 - Greff, Zoltan ; et al.	2004-04-01
Process for the preparation of amorphous atorvastatin calcium Grant 6,646,133 - Greff , et al. November 11, 2	2003-11-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.